This is an application for funding the General Clinical Research Center (GCRC) at the University of Kansas Medical Center (KUMC). The GCRC at KUMC is a joint partnership of the three primary schools: School of Medicine, School of Nursing, School of Allied Health, and the University of Kansas Hospital. The formation of the GCRC has been a high priority for these institutions. The planning process for the GCRC began in 2002. Over the next two years, institutional space and resources were identified and personnel were hired, equipment/supplies were purchased, and a GCRC Advisory Committee (GAC) was formed. In September 2004 protocols began to be reviewed and approved by the GAC. The GCRC opened its doors for research studies in January 2005. To date 48 protocols have been approved by the GAC. The GCRC was initiated with 4 aims: 1) to provide clinical investigators from the Schools of Medicine, Nursing, and Allied Health with optimal facilities and resources to conduct clinical research;2) to enhance multi-disciplinary research across all Departments and the three schools;3) to enable and train young faculty to become more involved in clinical research;and 4) to ultimately apply for federal funding to support the GCRC. We have made major progress toward these aims. Clinical investigators from all three schools, as well as those from the University of Kansas in Lawrence and Wichita, have been involved in all aspects of GCRC planning and implementation. The Program Director is an experienced clinical research investigator and reports directly to the Principal Investigator (PI), who serves as both the Executive Dean of the School of Medicine and the Executive Vice Chancellor of all three schools (Medicine, Nursing, Allied Health). The PI is committed to the GCRC and to advancing clinical research. The PI reports directly to the Chancellor of the University of Kansas, who is also committed to establishing and continuing our efforts to form a vibrant GCRC. The GCRC has become the focal point for performing investigator-initiated clinical research and for training young clinical investigators. Obtaining NIH funding for the GCRC will allow us to continue pursuing the aims we set in 2002 and thereby enhance the ability of our faculty to perform investigator-initiated, multidisciplinary, translational clinical research and to train the next generation of clinical investigators.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR023940-03
Application #
7575178
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Talbot, Bernard
Project Start
2007-04-15
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2011-03-31
Support Year
3
Fiscal Year
2009
Total Cost
$2,130,693
Indirect Cost
Name
University of Kansas
Department
Pathology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120
Shen, Chengli; Landsittel, Douglas; Irazabal, María V et al. (2017) Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis 69:482-484
Kline, Timothy L; Korfiatis, Panagiotis; Edwards, Marie E et al. (2017) Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int 92:1206-1216
Torres, Vicente E; Abebe, Kaleab Z; Schrier, Robert W et al. (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91:493-500
Morris, Jill K; Vidoni, Eric D; Johnson, David K et al. (2017) Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial. PLoS One 12:e0170547
Irazabal, María V; Abebe, Kaleab Z; Bae, Kyongtae Ty et al. (2017) Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. Nephrol Dial Transplant 32:1857-1865

Showing the most recent 10 out of 91 publications